Search Results 331-340 of 16967 for Cosmeceutical
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...
The purpose of this study is to learn about the effects, safety and how PF-06823859 is processed in adults with cutaneous lupus erythematosus (CLE) or systemic ...
Kermott CA, Schroeder DR, Kopecky SL, Behrenbeck TR. Cardiorespiratory Fitness and Coronary Artery Calcification in a Primary Prevention Population.
TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor- ...
About this study. This first-in-human clinical trial is a Phase 1/1b, open-label, sequential-group, dose-escalation and cohort expansion study evaluating ...
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...
violence. This policy is intended to foster all of Mayo Clinic's Values, including personal responsibility, individual accountability, and civility toward ...
About this study. The purpose of this study is to gain stepwise understanding of the fundamental biology governing human antitumor immunity, by systematic ...
The purpose of this study is to collect fat and blood vessel wall tissue for processing into adult stem cells and then test those cells for specific biological ...
This is a prospective, multi-center, non-randomized clinical evaluation utilizing the PulseRider® Aneurysm Neck Reconstruction Device. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.